Bulk L-theanine powder, 98–102% assay with specific rotation confirming the pure L-form. Enzymatically produced, non-animal, for beverages, capsules and gummies.
| Chemical name | N5-Ethyl-L-glutamine (L-glutamic acid gamma-monoethylamide); L-isomer only, not DL |
| CAS number | 3081-61-6 |
| Molecular formula | C7H14N2O3 — molecular weight 174.20 g/mol |
| Assay | 98.0–102.0% by HPLC (Japanese food-additive standard); 99% minimum grade also produced |
| Appearance | White crystalline powder, melting point about 174 °C; 1.0 g in 20 mL water gives a clear solution |
| Solubility | Readily water-soluble — 1 part in 2.6 parts water at 0 °C, 1.8 at 100 °C; insoluble in ethanol |
| Specific rotation | [a]D20 +7.7° to +8.5° — the check that confirms L-configuration and rules out racemic DL material |
| Loss on drying | Not more than 0.40%; sulfated residue on ignition NMT 0.2%; chloride NMT 0.02% |
| Heavy metals | Lead not more than 3 ppm, arsenic 2 ppm, cadmium 1 ppm, mercury 0.1 ppm |
| Origin and process | Enzymatic biosynthesis using glutaminase or gamma-glutamyltranspeptidase; non-animal, not tea extract |
| Shelf life | 24 months from manufacture in sealed original packaging, stored below 25 °C and away from light |
| HS code | 29241900 (India ITC-HS) — acyclic amides and their derivatives; salts thereof: other |
L-Theanine 98% minimum and 99% minimum, both enzymatically produced to the Japanese food-additive standard. Standard powder as stock; finer mesh cuts to order.
Bulk L-lysine monohydrochloride powder to USP/Ph. Eur. and food grade, assaying 98.5-101.5% on the dried basis and carrying approximately 80% lysine base. Fermentation-derived, non-animal origin.
Fermentation-derived L-leucine powder to USP, Ph. Eur. and JP, assaying 98.5-101.5% on the dried basis. Supplied in bulk for BCAA blends, sports nutrition and clinical formulations.
L-isoleucine powder to USP, Ph. Eur. and JP, assaying 98.5-101.5% on the dried basis with leucine and valine cross-isomers tightly controlled. Bulk export quantities for BCAA and clinical blends.